NCT03267498 2026-01-12
Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC)
University of California, San Francisco
Phase 2 Completed
University of California, San Francisco
Sichuan Cancer Hospital and Research Institute
King Faisal Specialist Hospital & Research Center